REQUEST A DEMO
Total
USD $0.00
Search more companies

Genesystem Co., Ltd (South Korea)

Main Activities: In-Vitro Diagnostic Substance Manufacturing | Electromedical and Electrotherapeutic Apparatus Manufacturing | Analytical Laboratory Instrument Manufacturing
Full name: Genesystem Co., Ltd Profile Updated: July 29, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Genesystem Co., Ltd is a company in South Korea, with a head office in Daejeon. The company operates in the In-Vitro Diagnostic Substance Manufacturing sector. It was incorporated on March 24, 2010. 52 (2025) employees currently work for Genesystem Co., Ltd. The company’s latest financial report indicates a net sales revenue increase of 419% in Q12026. During that time, Genesystem Co., Ltd’s total assets decreased by 44.21%. The enterprise’s net profit margin increased by 2591.66% in 2026.

Headquarters
200-9, Techno 2-Ro, Yuseong-Gu
Daejeon; Daejeon;

Contact Details: Purchase the Genesystem Co., Ltd report to view the information.

Website: http://www.genesystem.co.kr

Basic Information
Total Employees:
Purchase the Genesystem Co., Ltd report to view the information.
Outstanding Shares:
Purchase the Genesystem Co., Ltd report to view the information.
Registered Capital:
Purchase the Genesystem Co., Ltd report to view the information.
Financial Auditors:
Purchase the Genesystem Co., Ltd report to view the information.
Incorporation Date:
March 24, 2010
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Subsidiaries
㈜진시스템
Company Performance
Financial values in the chart are available after Genesystem Co., Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
419%
Total Operating Revenue
385.46%
Operating Profit
19.64%
EBITDA
11.82%
Net Profit/Loss for the Period
19.66%
Total Assets
-44.21%
Total Equity
-52.86%
Operating Profit Margin
2630.42%
Net Profit Margin
2591.66%
Return on Equity (ROE)
-6.86%
Debt / Equity
21.5%
Quick Ratio
0.05%
Cash Ratio
-0.31%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?